These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 970875)

  • 21. [Standardization of the laboratory method for antithrombin activity measurement].
    Okajima K
    Rinsho Byori; 2002 Mar; 50(3):283-6. PubMed ID: 11985057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Coagulation inhibitors in plasma and serum.
    Odegård OR; Abildgaard U
    Thromb Diath Haemorrh; 1975 Sep; 34(1):346. PubMed ID: 1188790
    [No Abstract]   [Full Text] [Related]  

  • 23. [Various aspects of blood coagulation in chronic pancreatitis with special reference to the antithrombin test].
    Facchini G; Fontana G; Cremonini GP; Scarcella D
    G Clin Med; 1969 Jan; 50(1):75-89. PubMed ID: 5386457
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of thrombin time, activities of antithrombin II and 3 following administration of cobalt (II) compounds in rabbits].
    Wohllebe W; Taube C; Fiedler H
    Z Gesamte Inn Med; 1968 Sep; 23(17):537-9. PubMed ID: 5715725
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heparin].
    Roszkowska W; Worowski K
    Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
    [No Abstract]   [Full Text] [Related]  

  • 26. [General mechanisms of coagulation and their physiological inhibition. II. The regulation of coagulation by physiological inhibitors].
    Guillin MC; Bezeaud A
    Pathol Biol (Paris); 1985 Nov; 33(9):917-32. PubMed ID: 2867516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural factors inhibiting blood coagulation (antithrombin III, protein C and protein S)].
    Wencel K
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):377-80. PubMed ID: 1437758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Natural inhibitors of coagulation in surgery as compared to blood donors].
    Frick G; Frick U
    Zentralbl Chir; 1972 Oct; 97(43):1535-40. PubMed ID: 4646690
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Inhibitory effects of estrogens on antithrombin III.
    Nagasawa H; Hotta Y; Takara N; Fujimaki M; Fukutake K
    Thromb Diath Haemorrh; 1975 Sep; 34(1):345. PubMed ID: 1188788
    [No Abstract]   [Full Text] [Related]  

  • 30. [Identification of antithrombin V and its behavior in the plasma and serum of the newborn infants and adults].
    Brüster H; Sturm H
    Z Kinderheilkd; 1966; 95(1):24-8. PubMed ID: 5983598
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heparin in therapeutics (author's transl)].
    Capel P
    Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood coagulation studies on the intimal cell. 5. Antithrombin activity of the intimal extract. 1].
    Oe K; Ota G; Okabe S
    Igaku To Seibutsugaku; 1967 Feb; 74(2):118-21. PubMed ID: 5624326
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of thrombin and autoprothrombin C (F-X a ) as a mutual depletion system.
    Dombrose FA; Seegers WH; Sedensky JA
    Thromb Diath Haemorrh; 1971 Aug; 26(1):103-23. PubMed ID: 5112369
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products].
    Stürner KH; Holzhüter H; Ochs HG; Angelkort B; Muchietti F; Wenzel E
    Verh Dtsch Ges Inn Med; 1973; 79():1328-30. PubMed ID: 4790173
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticoagulant activity of a synthetic heparinoid in relation to molecular weight and N-sulfate content.
    Sederel LC; van der Does L; van Duijl JF; Beugeling T; Bantjes A
    J Biomed Mater Res; 1981 Nov; 15(6):819-27. PubMed ID: 6171571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemistry of heparin (author's transl)].
    Yosizawa Z; Ototani N; Kosakai M
    Rinsho Ketsueki; 1981 Jul; 22(7):994-1000. PubMed ID: 7035720
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.